ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 29 filers reported holding ATYR PHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $10,000 | -41.2% | 28,236 | -6.3% | 0.00% | – |
Q1 2019 | $17,000 | +13.3% | 30,136 | 0.0% | 0.00% | – |
Q4 2018 | $15,000 | -37.5% | 30,136 | 0.0% | 0.00% | – |
Q3 2018 | $24,000 | -11.1% | 30,136 | -0.2% | 0.00% | – |
Q2 2018 | $27,000 | -66.2% | 30,208 | 0.0% | 0.00% | – |
Q1 2018 | $80,000 | -31.6% | 30,208 | -10.1% | 0.00% | – |
Q4 2017 | $117,000 | -33.9% | 33,618 | -4.5% | 0.00% | – |
Q3 2017 | $177,000 | +48.7% | 35,214 | -0.0% | 0.00% | – |
Q2 2017 | $119,000 | -3.3% | 35,220 | 0.0% | 0.00% | – |
Q1 2017 | $123,000 | +179.5% | 35,220 | +71.2% | 0.00% | – |
Q4 2016 | $44,000 | -31.2% | 20,575 | +1.9% | 0.00% | – |
Q3 2016 | $64,000 | -73.7% | 20,185 | -67.3% | 0.00% | – |
Q1 2016 | $243,000 | -60.0% | 61,708 | 0.0% | 0.00% | – |
Q4 2015 | $607,000 | -4.4% | 61,708 | -0.2% | 0.00% | – |
Q3 2015 | $635,000 | – | 61,855 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $33,854,000 | 15.10% |
EcoR1 Capital, LLC | 836,860 | $15,499,000 | 5.17% |
Rock Springs Capital Management LP | 408,496 | $7,565,000 | 0.55% |
BVF INC/IL | 134,725 | $2,495,000 | 0.44% |
Baker Brothers Advisors | 2,335,125 | $43,247,000 | 0.38% |
SPHERA FUNDS MANAGEMENT LTD. | 209,027 | $3,696,000 | 0.36% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 461,530 | $8,548,000 | 0.28% |
MARINER INVESTMENT GROUP LLC | 50,665 | $938,000 | 0.24% |
TIVERTON ASSET MANAGEMENT LLC | 450,000 | $8,334,000 | 0.17% |
RIVERHEAD CAPITAL MANAGEMENT LLC | 415,377 | $7,693,000 | 0.12% |